Markus from Luxembourg

Registered at the short selling broker Skilling, 3 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Abbott Laboratories (ABT) shares information

Abbott Laboratories


24h Change

-0.11 %

ABT

Live rate: Market closed

Stock data per Monday 25 Oct, 2021

ABT
NEW YORK STOCK EXCHANGE INC.
126.72
126.49
126.58
-0.14 (-0.11%)
US Market is closed

Live Stock price in graph for Abbott Laboratories (ABT)

  • Latest Volume

    4,426,906 (-22.91 %)

  • Volume prev. day

    5,742,356

  • Avg. daily volume

    5,541,504

  • Market cap

    224,403,220,036

  • P/E ratio

    35.56

  • Today high

    126.85 USD

  • Today low

    125.395 USD

  • 52 week high

    129.2 USD

  • 52 week low

    101.56 USD

  • YTD Change

    + 17.42 %

Quick links

 

Latest news about Abbott Laboratories

Below you can find the most recent news posts about Abbott Laboratories, primarily from US and UK based news sources.

Amundi Takes $427.62 Million Position in Abbott Laboratories (NYSE:ABT)

Monday, 25 October 2021, 18:50:43
Amundi bought a new stake in shares of Abbott Laboratories (NYSE:ABT) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 3,688,607 shares of the healthcare product makers stock, valued at approximately $427,622,000. Amundi owned 0.21% of Abbott Laboratories as of its most recent []
— Dakota Financial News


Abbott Laboratories (NYSE:ABT) Stock Position Lowered by Fairview Capital Investment Management LLC

Monday, 25 October 2021, 15:38:41
Fairview Capital Investment Management LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT) by 3.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,615 shares of the healthcare product makers stock after selling 207 shares during the quarter. Fairview Capital Investment Management []
— Dakota Financial News


Infectious Disease Diagnostic Market Top Key Players, Industry Analysis And Forecast By 2027 | Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieu- SA

Monday, 25 October 2021, 14:05:44
A comprehensive overview of the Infectious Disease Diagnostic market is recently added by UnivDatos Market Insights to its humongous database. The Infectious Disease Diagnostic market report has been aggregated by collecting informative data of various dynamics such as market drivers,
— OpenPR


Morgan Stanley Raises Abbott Laboratories (NYSE:ABT) Price Target to $146.00

Monday, 25 October 2021, 09:06:41
Abbott Laboratories (NYSE:ABT) had its target price boosted by Morgan Stanley from $136.00 to $146.00 in a report released on Thursday morning, The Fly reports. Morgan Stanley currently has an overweight rating on the healthcare product makers stock. Several other analysts have also recently weighed in on the stock. Credit Suisse Group raised their price []
— Dakota Financial News


Abbott Laboratories (ABT) Market Perform Rating Reaffirmed at SVB Leerink

Monday, 25 October 2021, 09:06:41
SVB Leerink reissued their market perform rating on shares of Abbott Laboratories (NYSE:ABT) in a report issued on Thursday, Analyst Ratings Network reports. The firm currently has a $140.00 price objective on the healthcare product makers stock, up from their previous price objective of $128.00. SVB Leerink also issued estimates for Abbott Laboratories Q4 2021 []
— Dakota Financial News


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have ABT available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.